AAAAAA

   
Results: 1-25 | 26-50 | 51-65
Results: 1-25/65
THE USE OF A RETINOID RECEPTOR ANTAGONIST IN A NEW MODEL TO STUDY VITAMIN-A-DEPENDENT DEVELOPMENTAL EVENTS
Authors: KOCHHAR DM JIANG H PENNER JD JOHNSON AT CHANDRARATNA RAS
Citation: Dm. Kochhar et al., THE USE OF A RETINOID RECEPTOR ANTAGONIST IN A NEW MODEL TO STUDY VITAMIN-A-DEPENDENT DEVELOPMENTAL EVENTS, The International journal of developmental biology, 42(4), 1998, pp. 601-608
RATIONAL DESIGN OF RECEPTOR-SELECTIVE RETINOIDS
Authors: CHANDRARATNA RAS
Citation: Ras. Chandraratna, RATIONAL DESIGN OF RECEPTOR-SELECTIVE RETINOIDS, Journal of the American Academy of Dermatology, 39(4), 1998, pp. 124-128
FUTURE-TRENDS - A NEW-GENERATION OF RETINOIDS
Authors: CHANDRARATNA RAS
Citation: Ras. Chandraratna, FUTURE-TRENDS - A NEW-GENERATION OF RETINOIDS, Journal of the American Academy of Dermatology, 39(4), 1998, pp. 149-152
ONCE-DAILY TAZAROTENE GEL VERSUS TWICE-DAILY FLUOCINONIDE CREAM IN THE TREATMENT OF PLAQUE PSORIASIS
Authors: LEBWOHL M AST E CALLEN JP CULLEN SI HONG SR KULPSHORTEN CL LOWE NJ PHILLIPS TJ ROSEN T WOLF DI QUELL JM SEFTON J LUE JC GIBSON JR CHANDRARATNA RAS
Citation: M. Lebwohl et al., ONCE-DAILY TAZAROTENE GEL VERSUS TWICE-DAILY FLUOCINONIDE CREAM IN THE TREATMENT OF PLAQUE PSORIASIS, Journal of the American Academy of Dermatology, 38(5), 1998, pp. 705-711
RETINOIC ACID ALTERS THE INTRACELLULAR TRAFFICKING OF THE MANNOSE-6-PHOSPHATE INSULIN-LIKE-GROWTH-FACTOR-II RECEPTOR AND LYSOSOMAL-ENZYMES
Authors: KANG JX BELL J LEAF A BEARD RL CHANDRARATNA RAS
Citation: Jx. Kang et al., RETINOIC ACID ALTERS THE INTRACELLULAR TRAFFICKING OF THE MANNOSE-6-PHOSPHATE INSULIN-LIKE-GROWTH-FACTOR-II RECEPTOR AND LYSOSOMAL-ENZYMES, Proceedings of the National Academy of Sciences of the United Statesof America, 95(23), 1998, pp. 13687-13691
LIGAND INDUCTION OF RETINOIC ACID RECEPTORS ALTERS AN ACUTE INFECTIONBY MURINE CYTOMEGALOVIRUS
Authors: ANGULO A CHANDRARATNA RAS LEBLANC JF GHAZAL P
Citation: A. Angulo et al., LIGAND INDUCTION OF RETINOIC ACID RECEPTORS ALTERS AN ACUTE INFECTIONBY MURINE CYTOMEGALOVIRUS, Journal of virology, 72(6), 1998, pp. 4589-4600
THE SAFETY AND EFFICACY OF TAZAROTENE GEL, A TOPICAL ACETYLENIC RETINOID, IN THE TREATMENT OF PSORIASIS
Authors: KRUEGER GG DRAKE LA ELIAS PM LOWE NJ GUZZO C WEINSTEIN GD LEWKAYA DA LUE JC SEFTON J CHANDRARATNA RAS
Citation: Gg. Krueger et al., THE SAFETY AND EFFICACY OF TAZAROTENE GEL, A TOPICAL ACETYLENIC RETINOID, IN THE TREATMENT OF PSORIASIS, Archives of dermatology, 134(1), 1998, pp. 57-60
SYNTHESIS AND BIOLOGICAL-ACTIVITY OF 1,2,3,4-TETRAHYDROQUINOLINE AND 3,4-(1H)-DIHYDROQUINOLIN-2-ONE ANALOGS OF RETINOIC ACID
Authors: BEARD RL TENG M COLON DF DUONG TT THACHER SM AREFIEG T CHANDRARATNA RAS
Citation: Rl. Beard et al., SYNTHESIS AND BIOLOGICAL-ACTIVITY OF 1,2,3,4-TETRAHYDROQUINOLINE AND 3,4-(1H)-DIHYDROQUINOLIN-2-ONE ANALOGS OF RETINOIC ACID, Bioorganic & medicinal chemistry letters, 7(18), 1997, pp. 2373-2378
LACK OF INVOLVEMENT OF RETINOIC ACID RECEPTOR-ALPHA IN RETINOID-INDUCED SKIN IRRITATION IN HAIRLESS MICE
Authors: STANDEVEN AM TENG M CHANDRARATNA RAS
Citation: Am. Standeven et al., LACK OF INVOLVEMENT OF RETINOIC ACID RECEPTOR-ALPHA IN RETINOID-INDUCED SKIN IRRITATION IN HAIRLESS MICE, Toxicology letters, 92(3), 1997, pp. 231-240
RETINOID ANTAGONISM OF NF-IL6 - INSIGHT INTO THE MECHANISM OF ANTIPROLIFERATIVE EFFECTS OF RETINOIDS IN KAPOSIS-SARCOMA
Authors: NAGPAL S CAI J ZHENG T PATEL S MASOOD R LIN GY FRIANT S JOHNSON A SMITH DL CHANDRARATNA RAS GILL PS
Citation: S. Nagpal et al., RETINOID ANTAGONISM OF NF-IL6 - INSIGHT INTO THE MECHANISM OF ANTIPROLIFERATIVE EFFECTS OF RETINOIDS IN KAPOSIS-SARCOMA, Molecular and cellular biology, 17(7), 1997, pp. 4159-4168
TAZAROTENE - THE FIRST RECEPTOR-SELECTIVE TOPICAL RETINOID FOR THE TREATMENT OF PSORIASIS
Authors: CHANDRARATNA RAS
Citation: Ras. Chandraratna, TAZAROTENE - THE FIRST RECEPTOR-SELECTIVE TOPICAL RETINOID FOR THE TREATMENT OF PSORIASIS, Journal of the American Academy of Dermatology, 37(2), 1997, pp. 12-17
MOLECULAR MECHANISMS OF TAZAROTENE ACTION IN PSORIASIS
Authors: DUVIC M NAGPAL S ASANO AT CHANDRARATNA RAS
Citation: M. Duvic et al., MOLECULAR MECHANISMS OF TAZAROTENE ACTION IN PSORIASIS, Journal of the American Academy of Dermatology, 37(2), 1997, pp. 18-24
TAZAROTENE GEL, A NEW RETINOID, FOR TOPICAL THERAPY OF PSORIASIS - VEHICLE-CONTROLLED STUDY OF SAFETY, EFFICACY, AND DURATION OF THERAPEUTIC EFFECT
Authors: WEINSTEIN GD KRUEGER GG LOWE NJ DUVIC M FRIEDMAN DJ JEGASOTHY BV JORIZZO JL SHMUNES E TSCHEN EH LEWKAYA DA LUE JC SEFTON J GIBSON JR CHANDRARATNA RAS
Citation: Gd. Weinstein et al., TAZAROTENE GEL, A NEW RETINOID, FOR TOPICAL THERAPY OF PSORIASIS - VEHICLE-CONTROLLED STUDY OF SAFETY, EFFICACY, AND DURATION OF THERAPEUTIC EFFECT, Journal of the American Academy of Dermatology, 37(1), 1997, pp. 85-92
RECEPTOR SPECIFICITY OF RETINOID-INDUCED EPIDERMAL HYPERPLASIA - EFFECT OF RXR-SELECTIVE AGONISTS AND CORRELATION WITH TOPICAL IRRITATION
Authors: THACHER SM STANDEVEN AM ATHANIKAR J KOPPER S CASTILLEJA O ESCOBAR M BEARD RL CHANDRARATNA RAS
Citation: Sm. Thacher et al., RECEPTOR SPECIFICITY OF RETINOID-INDUCED EPIDERMAL HYPERPLASIA - EFFECT OF RXR-SELECTIVE AGONISTS AND CORRELATION WITH TOPICAL IRRITATION, The Journal of pharmacology and experimental therapeutics, 282(2), 1997, pp. 528-534
IDENTIFICATION OF HIGHLY POTENT RETINOIC ACID RECEPTOR ALPHA-SELECTIVE ANTAGONISTS
Authors: TENG M DUONG TT JOHNSON AT KLEIN ES WANG LM KHALIFA B CHANDRARATNA RAS
Citation: M. Teng et al., IDENTIFICATION OF HIGHLY POTENT RETINOIC ACID RECEPTOR ALPHA-SELECTIVE ANTAGONISTS, Journal of medicinal chemistry, 40(16), 1997, pp. 2445-2451
TAZAROTENE-INDUCED-GENE-2 (TIG2), A NOVEL RETINOID-RESPONSIVE GENE INSKIN
Authors: NAGPAL S PATEL S JACOBE H DISEPIO D GHOSN C MALHOTRA M TENG M DUVIC M CHANDRARATNA RAS
Citation: S. Nagpal et al., TAZAROTENE-INDUCED-GENE-2 (TIG2), A NOVEL RETINOID-RESPONSIVE GENE INSKIN, Journal of investigative dermatology, 109(1), 1997, pp. 91-95
INTERFERON-INDUCIBLE PROTEIN-10 IS REDUCED BY TREATMENT WITH RAR SPECIFIC RETINOIDS IN PSORIASIS AND KERATINOCYTE CULTURES
Authors: HAZARIKA P DUONG DMT HAGER C HAKINZADEH M SARRIS A NAGPAL S THACHER S CHANDRARATNA RAS DUVIC M
Citation: P. Hazarika et al., INTERFERON-INDUCIBLE PROTEIN-10 IS REDUCED BY TREATMENT WITH RAR SPECIFIC RETINOIDS IN PSORIASIS AND KERATINOCYTE CULTURES, Journal of investigative dermatology, 108(4), 1997, pp. 204-204
TAZAROTENE AN RAR SELECTIVE RETINOID, AFFECTS THE EXPRESSION OF GENESASSOCIATED WITH ABNORMAL DIFFERENTIATION, HYPERPROLIFERATION AND INFLAMMATION
Authors: NAGPAL S GHOSN C DISEPIO D MALHOTRA M PATEL S JACOBE H HAGER C THACHER S DUVIC M CHANDRARATNA RAS
Citation: S. Nagpal et al., TAZAROTENE AN RAR SELECTIVE RETINOID, AFFECTS THE EXPRESSION OF GENESASSOCIATED WITH ABNORMAL DIFFERENTIATION, HYPERPROLIFERATION AND INFLAMMATION, Journal of investigative dermatology, 108(4), 1997, pp. 245-245
RETINOID INHIBITION OF MRP-8 VIA ANTAGONISM OF NF-IL6 ENHANCER ACTIVITY - A NOVEL MECHANISM OF GENE-REGULATION
Authors: DISEPIO D MALHOTRA M CHANDRARATNA RAS NAGPAL S
Citation: D. Disepio et al., RETINOID INHIBITION OF MRP-8 VIA ANTAGONISM OF NF-IL6 ENHANCER ACTIVITY - A NOVEL MECHANISM OF GENE-REGULATION, Journal of investigative dermatology, 108(4), 1997, pp. 246-246
IDENTIFICATION OF RETINOIC ACID RECEPTOR INVERSE AGONISTS AND THEIR POTENTIAL USE AS THERAPEUTIC AGENTS
Authors: KLEIN ES PINO ME JOHNSON AT NAGPAL S THACHER S KRASINSKI G CHANDRARATNA RAS
Citation: Es. Klein et al., IDENTIFICATION OF RETINOIC ACID RECEPTOR INVERSE AGONISTS AND THEIR POTENTIAL USE AS THERAPEUTIC AGENTS, Journal of investigative dermatology, 108(4), 1997, pp. 249-249
VITAMIN-D SUPPRESSES HUMAN ECTOCERVICAL KERATINOCYTE PROLIFERATION AND INCREASES INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 (IGFBP-3)
Authors: AGARWAL C CHANDRARATNA RAS RORKE EA ECKERT RL
Citation: C. Agarwal et al., VITAMIN-D SUPPRESSES HUMAN ECTOCERVICAL KERATINOCYTE PROLIFERATION AND INCREASES INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 (IGFBP-3), Journal of investigative dermatology, 108(4), 1997, pp. 252-252
ANTAGONISM OF TRANSCRIPTION FACTOR ACTION - A MAJOR-MODE OF THERAPEUTIC ACTION OF RETINOIDS
Authors: NAGPAL S DISEPIO D MALHOTRA M GHOSN C DUVIC M CHANDRARATNA RAS
Citation: S. Nagpal et al., ANTAGONISM OF TRANSCRIPTION FACTOR ACTION - A MAJOR-MODE OF THERAPEUTIC ACTION OF RETINOIDS, Journal of investigative dermatology, 108(4), 1997, pp. 297-297
INTERFERON REGULATION OF PROLIFERATION AND INSULIN-LIKE GROWTH-FACTORBINDING-PROTEIN EXPRESSION IN HUMAN ECTOCERVICAL KERATINOCYTES
Authors: HEMBREE JR AGARWAL C EFIMOVA T CHANDRARATNA RAS ECKERT RL
Citation: Jr. Hembree et al., INTERFERON REGULATION OF PROLIFERATION AND INSULIN-LIKE GROWTH-FACTORBINDING-PROTEIN EXPRESSION IN HUMAN ECTOCERVICAL KERATINOCYTES, Journal of investigative dermatology, 108(4), 1997, pp. 483-483
TAZAROTENE 0.1-PERCENT GEL IS ASSOCIATED WITH ALTERATIONS IN MARKERS OF EPIDERMAL DIFFERENTIATION AND INFLAMMATION IN PSORIATIC PLAQUES
Authors: HAGER C DIMAIO D MAYS S ANGEL T CUNNINGHAM MA LEDBETTER L SEFTON J THACHER SM NAGPAL S CHANDRARATNA RAS DUVIC M
Citation: C. Hager et al., TAZAROTENE 0.1-PERCENT GEL IS ASSOCIATED WITH ALTERATIONS IN MARKERS OF EPIDERMAL DIFFERENTIATION AND INFLAMMATION IN PSORIATIC PLAQUES, Journal of investigative dermatology, 108(4), 1997, pp. 712-712
RETINOID AGONISTS AND INVERSE AGONISTS - A NEW-GENERATION
Authors: CHANDRARATNA RAS THACHER SM KLEIN ES
Citation: Ras. Chandraratna et al., RETINOID AGONISTS AND INVERSE AGONISTS - A NEW-GENERATION, Journal of investigative dermatology, 108(3), 1997, pp. 114-114
Risultati: 1-25 | 26-50 | 51-65